Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intra operative computer-optimized conformal planning technique

被引:65
作者
Zelefsky, MJ
Yamada, Y
Cohen, G
Venkatraman, ES
Fung, AYC
Furhang, E
Silvern, D
Zaider, M
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[4] Rabin Med Ctr, Dept Med Phys, Petah Tiqwa, Israel
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 48卷 / 02期
关键词
prostate cancer; brachytherapy; dosimetry; conformal; genetic algorithm;
D O I
10.1016/S0360-3016(00)00655-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the target coverage and dose to normal tissues after I-125 transperineal permanent implantation (TPI) of the prostate in 90 patients treated with one of three different transperineal techniques. Methods and Materials: Detailed postimplant dosimetric evaluations of permanent I-125 implantation procedures were performed on 30 consecutive patients treated between 1995-1996 who underwent TPI using a preplanning CT-based technique, on 30 consecutive patients treated in 1997-1998 who underwent an ultrasound-guided approach with intraoperative determination of seed distribution based on an I-125 nomogram, and on 30 consecutive patients in 1998-1999 who underwent TPI with intraoperative computer-based 3-dimensional conformal optimization. For all three techniques, postimplant CT scans were obtained 4-6 hours after TPI, Dosimetric parameters included V-100, V-90, V-150, D-100, D-90, D-80, as well as maximal and average doses to the urethra and rectal wall. These parameter outcomes are reported as a percentage of the prescription dose. Results: The intraoperative 3D-optimized technique (I-3D) provided superior target coverage with the prescription dose for all dosimetric variables evaluated compared to the other treatment techniques. The median V-100, V-90, and D-90 values for the I-3D technique were 96%, 98%, and 116%, respectively. In contrast, the V-100, V-90, and D-90 values for the CT preplan and ultrasound manual optimization approaches were 86%, 89%, and 88%, respectively and 88%, 92%, and 94%, respectively (I-3D versus other techniques: p < 0.001). The superior target coverage with the I-3D technique was also associated with a higher cumulative implant activity required by the optimization program. A multivariate analysis determined that the treatment technique (I-3D versus other approaches) was an independent predictor of improved target coverage for each parameter analyzed (p < 0.001). in addition, higher cumulative implant activities and smaller prostate target volumes were independent predictors of improved target coverage, The maximum and average urethral doses were significantly lower with the I-3D technique compared to the other techniques; a modest increase in the average rectal dose was also observed with this approach, Conclusion: Three-dimensional intraoperative computer optimized TPI consistently provided superior target coverage with the prescription dose and significantly lower urethral doses compared to two other techniques used. These data provide proof-of-principle that improved therapeutic ratios can be achieved with the integration of more sophisticated intraoperative planning for TPI and may potentially have a profound impact on the outcome of patients treated with this modality. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:601 / 608
页数:8
相关论文
共 28 条
  • [1] [Anonymous], BRACHYTHERAPY ONCOLO
  • [2] Biochemical disease-free survival following I-125 prostate implantation
    Beyer, DC
    Priestley, JB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03): : 559 - 563
  • [3] Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy
    Bice, WS
    Prestidge, BR
    Grimm, PD
    Friedland, JL
    Feygelman, V
    Roach, M
    Prete, JL
    Dubois, DF
    Blasko, JC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04): : 921 - 927
  • [4] PROSTATE-SPECIFIC ANTIGEN BASED DISEASE-CONTROL FOLLOWING ULTRASOUND-GUIDED (125)IODINE IMPLANTATION FOR STAGE T1/T2 PROSTATIC-CARCINOMA
    BLASKO, JC
    WALLNER, K
    GRIMM, PD
    RAGDE, H
    [J]. JOURNAL OF UROLOGY, 1995, 154 (03) : 1096 - 1099
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants
    Kini, VR
    Edmundson, GK
    Vicini, FA
    Jaffray, DA
    Gustafson, G
    Martinez, AA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 571 - 578
  • [7] Potential role of various dosimetric quality indicators in prostate brachytherapy
    Merrick, GS
    Butler, WM
    Dorsey, AT
    Lief, JH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 717 - 724
  • [8] MESSING EM, 1999, INT J RADIAT ONCOL, V43, P647
  • [9] American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer
    Nag, S
    Beyer, D
    Friedland, J
    Grimm, P
    Nath, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04): : 789 - 799
  • [10] DOSIMETRY OF INTERSTITIAL BRACHYTHERAPY SOURCES - RECOMMENDATIONS OF THE AAPM RADIATION-THERAPY COMMITTEE TASK GROUP NO 43
    NATH, R
    ANDERSON, LL
    LUXTON, G
    WEAVER, KA
    WILLIAMSON, JF
    MEIGOONI, AS
    [J]. MEDICAL PHYSICS, 1995, 22 (02) : 209 - 234